HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Yasuda Selected Research

Oxidized LDL Receptors

4/2012Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis.
11/2004Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.
11/2002LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death-possible role of dephosphorylation of Akt.
9/2002Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Yasuda Research Topics

Disease

11Osteoarthritis
01/2014 - 11/2002
11Rheumatoid Arthritis
04/2012 - 01/2003
4Stomach Neoplasms (Stomach Cancer)
08/2013 - 10/2008
4Arthritis (Polyarthritis)
04/2012 - 09/2002
3Pain (Aches)
01/2022 - 03/2010
3Hypertrophy
11/2011 - 05/2007
2Inflammation (Inflammations)
01/2018 - 07/2011
2Vascular Remodeling
11/2017 - 07/2011
2Hypoxia (Hypoxemia)
11/2017 - 12/2016
2Infections
11/2012 - 02/2011
2Neoplasms (Cancer)
08/2012 - 08/2004
2Pulmonary Hypertension
11/2011 - 01/2009
2Breast Neoplasms (Breast Cancer)
09/2011 - 10/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2010 - 10/2008
2Chondrosarcoma
02/2008 - 01/2008
1Hip Osteoarthritis (Coxarthrosis)
01/2022
1Knee Osteoarthritis
10/2021
1Hemorrhage
03/2021
1Peri-Implantitis
03/2021
1Disease Progression
07/2020
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2019
1Periodontitis
03/2017
1Obesity
07/2015
1Hyperuricemia
07/2015
1Colorectal Neoplasms (Colorectal Cancer)
10/2013
1Hypersensitivity (Allergy)
02/2013
1Fatigue
08/2012
1Anorexia
08/2012
1Herpes Zoster
02/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2011
1Opportunistic Infections (Opportunistic Infection)
02/2011
1Stroke (Strokes)
10/2010
1Ischemia
10/2010
1Neutropenia
01/2010
1Thrombocytopenia (Thrombopenia)
12/2009
1Chronic Kidney Failure (Chronic Renal Failure)
01/2009
1Pulmonary Embolism
01/2009

Drug/Important Bio-Agent (IBA)

9Hyaluronic Acid (Hyaluronan)IBA
01/2014 - 08/2004
5Fibronectins (Fibronectin)IBA
06/2011 - 01/2006
4Oxidized LDL ReceptorsIBA
04/2012 - 09/2002
4LectinsIBA
04/2012 - 09/2002
3Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
04/2012 - 09/2002
3oxidized low density lipoproteinIBA
04/2012 - 09/2002
3Collagenases (Collagenase)FDA Link
01/2008 - 01/2003
2Biomarkers (Surrogate Marker)IBA
03/2021 - 04/2012
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2017 - 12/2016
2S-1 plus cisplatinIBA
08/2013 - 08/2012
2Pharmaceutical PreparationsIBA
02/2013 - 10/2010
2fasudil (AT 877)IBA
11/2011 - 07/2011
2rho-Associated KinasesIBA
11/2011 - 07/2011
2Heparin (Liquaemin)FDA LinkGeneric
11/2010 - 01/2007
2Paclitaxel (Taxol)FDA LinkGeneric
01/2010 - 10/2008
2Matrix Metalloproteinases (MMPs)IBA
01/2008 - 01/2003
2CollagenIBA
09/2006 - 01/2003
14-hexyloxyaniline (HOA)IBA
01/2022
1Tuberculin (PPD)IBA
03/2021
1LipopolysaccharidesIBA
03/2021
1Biological ProductsIBA
07/2020
1Immunoglobulin A (IgA)IBA
01/2019
1Semaxinib (SU5416)IBA
11/2017
1Sirolimus (Rapamycin)FDA Link
11/2017
1ambrisentanFDA Link
12/2016
1Phenobarbital (Luminal)FDA Link
12/2016
1Endothelin Receptor AntagonistsIBA
12/2016
1Allopurinol (Remid)FDA LinkGeneric
07/2015
1Uric Acid (Urate)IBA
07/2015
1FebuxostatFDA Link
07/2015
1Bevacizumab (Avastin)FDA Link
10/2013
1Cisplatin (Platino)FDA LinkGeneric
08/2013
1tegafur-gimeracil-oteracilIBA
08/2013
1PotassiumIBA
08/2013
1PlatinumIBA
02/2013
1taxaneIBA
02/2013
1Anti-Bacterial Agents (Antibiotics)IBA
11/2012
1Neutralizing AntibodiesIBA
04/2012
1EnzymesIBA
04/2012
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
11/2011
1Trastuzumab (Herceptin)FDA Link
09/2011
1Acyclovir (Aciclovir)FDA LinkGeneric
02/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2010
1p38 Mitogen-Activated Protein KinasesIBA
11/2010
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2010
1Neuroprotective AgentsIBA
10/2010
1Inflammation MediatorsIBA
03/2010
1ProstaglandinsIBA
03/2010
1Prostaglandins EIBA
03/2010
1CreatinineIBA
01/2010
1Carboplatin (JM8)FDA LinkGeneric
01/2010
1GemcitabineFDA Link
12/2009
1Bosentan (Tracleer)FDA Link
01/2009

Therapy/Procedure

7Drug Therapy (Chemotherapy)
10/2013 - 02/2008
5Intra-Articular Injections
01/2014 - 11/2009
4Therapeutics
08/2013 - 01/2006
2Knee Replacement Arthroplasty (Total Knee Replacement)
10/2021 - 01/2018
2Adjuvant Chemotherapy
09/2011 - 05/2010
1Debridement
03/2021
1Solid-State Lasers
03/2021
1Cryotherapy (Therapy, Cold)
01/2018
1Oral Hygiene (Dental Hygiene)
03/2017
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2011